Upgrade to SI Premium - Free Trial

CVS Health (CVS) PT Raised to $89 at UBS

February 10, 2017 8:51 AM
UBS analyst Michael Cherny reiterates Buy rating and raises price target on CVS Health Corp. (NYSE: CVS) to $89 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles